PolarityTE to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright Global Life Sciences Virtual Conference held March 9-10, 2021.
Stella Diagnostics Announces Key Additions to its Board of Directors
SALT LAKE CITY, UT / ACCESSWIRE / February 25, 2021 / . (OTC PINK:JMDP) ("Stella" or "The Company") today announced that it has appointed Peter A. Cohen, Seth Platt, and David Seaburg to its Board of Directors. The three new members have decades of experience in asset management, investment banking and corporate development - having held various executive roles for multiple leading, global institutions.
Thinking about buying stock in Polarityte, Moleculin Biotech, InspireMD, US Well Services, or Resonant?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PTE, MBRX, NSPR, USWS, and RESN.
Thinking about buying stock in Polarityte, Jaguar Health, SRAX, ReneSola, or Marathon Patent Group?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PTE, JAGX, SRAX, SOL, and MARA.
Unprecedented Global Events Lead Diagnostic Providers to Innovative Breakthroughs
, /PRNewswire/ -- As the pandemic continues to spread throughout the U.S., the need for testing is on the rise as well. Nevertheless, many states and regions are experiencing a shortage of tests, which is a serious obstacle in the fight against the spread of the viral infection, COVID-19. According to the report by the from back in July, at a testing site in , a line formed at dawn; yet city officials ran out of tests five minutes after the doors opened at , and many people had to be turned away. Overall, testing continues to be a very uneven, as some states have managed to provided higher rates of testing than others. In , Governor announced last week that a record number of tests were performed statewide on Friday, indicating that 102,925 test results were performed on in one day with a statewide infection rate of 0.82%. Cuomo explained that the "record-high number of tests helps the state make informed decisions to protect the welfare of New Yorkers, and helps them make informed decisions for themselves. But testing alone isn't enough, and we need residents to continue to wear masks, socially distance and wash their hands." Todos Medical Ltd. (OTC: TOMDF), Aytu BioScience, Inc. (NASDAQ: AYTU), Co-Diagnostics, Inc. (NASDAQ: CODX), OPKO Health, Inc. (NASDAQ: OPK), Dynavax Technologies Corporation (NASDAQ: DVAX)
Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
, /PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq: CODX), (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today announced that it has entered into an agreement with Arches Research, Inc, a CLIA laboratory and subsidiary of Polarity TE, Inc, (Nasdaq: PTE), to expand Arches' COVID-19 testing services using Co-Diagnostics' Logix Smart™ COVID-19 test kit.
PolarityTE Announces Strategic Partnership with Co-Diagnostics to Expand COVID-19 Testing Platform
PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced that its subsidiary, Arches Research, Inc., has entered into a strategic partnership with Co-Diagnostics, Inc. (Nasdaq: CODX) to expand COVID-19 testing operations.
Bragar Eagel & Squire is Investigating Certain Officers and Directors of PolarityTE, comScore, AMC, and Conagra Brands and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of PolarityTE, Inc. (NASDAQ: PTE), comScore, Inc. (NASDAQ: SCOR), AMC Entertainment Holdings, Inc. (NYSE: AMC), and Conagra Brands, Inc. (NYSE: CAG) on behalf of long-term stockholders. More information about each potential case can be found at the link provided.
Bragar Eagel & Squire is Investigating Certain Officers and Directors of National General Holdings, Natural Health Trends, Omnicell, and Polarity TE and Encourages Investors to Contact the Firm
Bragar Eagel & Squire is investigating certain officers and directors of National General Holdings Corp. (NASDAQ: NGHC), Natural Health Trends Corp. (NASDAQ: NHTC), Omnicell, Inc. (NASDAQ: OMCL), and PolarityTE, Inc. (NASDAQ: PTE) on behalf of long-term stockholders. More information about each potential case can be found at the link provided.